SOL GROUP INVESTMENTS During the 2022 financial year, investments were made for Euro 58.2 million in the “technical gases“ sector, of which Euro 20.4 million by the parent company SOL Spa, and Euro 73.0 million in the “home care“ sector. The main investments made were as follows: • in Verona, Italy, at IL POINT, work was completed on modernising the entire site with the creation of the new area dedicated to orthopaedics and the creation of the new centre for orthopaedic prostheses; • in Burago, Italy, work began on the construction of VIVISOL Srl’s new logistics centre; • in Cremona, the work to upgrade the storage and compression of gaseous helium was completed; • in Tilburg, the Netherlands, the modernisation of the nitrous oxide production plant was completed; • in Slovenia, the new TPJ company headquarters were built in Jesenice; • in Florina, Greece, work began on upgrading TAE’s carbon dioxide production plant; • in India, work began on the construction of a new air fractionation plant for the production of oxygen, nitrogen and argon in Ranipet (Tamil Nadu); • the programme for the improvement, modernisation and rationalisation of primary production plants of technical gases continued. This activity concerned in particular the units at Tanagra in Greece and Trichy in India; • the programme for the improvement, modernisation and rationalisation of secondary production plants of technical and medical gases continued. This activity concerned in particular the units in Catania in Italy, Aspropyrgos in Greece and Sisak in Croatia; • a number of on-site industrial and medical systems were built and launched in Italy as well as abroad, and means of transport, distribution and product sales have been enhanced with the purchase of cryogenic tanks, cryogenic liquid distribution reservoirs, cylinders, dewars and electrical medical devices, all to sustain the group’s development in all sectors of activity and geographic areas; • investments continued to improve IT systems for both the technical gas and home-care sectors.
MAJOR CORPORATE TRANSACTIONS During 2022, several acquisitions were made, both in Italy and abroad. The most important ones are highlighted below: • the Brazilian subsidiary P PAR Ltda acquired 60% of BLA SERVIÇOS HOSPITALARES Ltda e JML SERVIÇOS HOSPITALARES Ltda, companies located in São Paulo (Brazil) and operating in the hospital business; • the subsidiary company VIVISOL DEUTSCHLAND GmbH acquired 100% of the German company PROFI GESUNDHEITS - SERVICE GmbH, operating in the home-care sector; • the subsidiary AIRSOL Srl acquired 51% of the company ITOP Spa OFFICINE ORTOPEDICHE, a company operating in the design, production, research and innovation of ortho-prosthetic devices for orthopaedic and neuromuscular pathologies; • the subsidiary AIRSOL Srl acquired 61% of the Irish company POLAR ICE Ltd active in the production and marketing of dry ice; • the parent company SOL Spa, with the support of SIMEST, acquired 100% of the Indian company GREEN ASU PLANT PRIVATE Ltd, which is active in the production and marketing of technical and medical gases and the production of renewable wind energy; moreover, again with the support of SIMEST, SOL Spa acquired 51% of the Indian company BHORUKA SPECIALTY GASES PRIVATE Ltd, which is engaged in the production and marketing of pure, very pure and specialty gases.
Half‐yearly financial report of the SOL Group as at 30 June 2023 With regard to M&A, it should be noted that during the first half of the year, the subsidiary Airsol Srl acquired the majority of the capital of Swissgas and ICP ‐ Industrias Criogenica del Peru, companies active in the technical gas sector in Ecuador and Peru.
RLT Price at posting:
87.5¢ Sentiment: Buy Disclosure: Held
(20min delay)